Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
---|---|---|---|---|
6/30/2025 | $ 14.7M | 1 | 9.49M | $ 1.55 |
3/31/2025 | $ 7.18M | 1 | 9.48M | $ 0.76 |
12/31/2024 | $ 7.57M | 1 | 5.18M | $ 1.46 |
9/30/2024 | $ 9.21M | 1 | 4.68M | $ 1.97 |
6/30/2024 | $ 13.91M | 1 | 4.65M | $ 2.99 |
3/31/2024 | $ 8.91M | 1 | 4.65M | $ 1.92 |
12/31/2023 | $ 5.12M | 1 | 4.53M | $ 1.13 |
9/30/2023 | $ 3.2M | 1 | 4.61M | $ 0.7 |
6/30/2023 | $ 8.61M | 1 | 4.59M | $ 1.87 |
3/31/2023 | $ 8.64M | 1 | 4.3M | $ 2.01 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues / (Shares WA * Share Factor)
(=) SPS
SPS for VERRICA PHARMACEUTICALS INC is calculated as follows: Revenues [ $ 0 ] / (Shares WA [ 2.5M ] * Share Factor [ 1 ])
(=) SPS [ $ 0 ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.63K |
---|---|
min | $ -18.02 |
max | $ 54.8 |
average | $ 11.55 |
median | $ 5.89 |
std | $ 13.62 |